![](/img/cover-not-exists.png)
35TiPRibociclib plus goserelin with hormonal therapy versus physician choice chemotherapy in pre-/perimenopausal patients with HR+, HER2– inoperable locally advanced breast cancer (ABC): RIGHT choice study
Lu, Y-S, Malwinder, S S, Azim, H, Eralp, Y, Im, S-A, Yap, Y S, Alfaro, T Delgar, Gao, M, Saghir, N S ElVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz417.010
Date:
November, 2019
File:
PDF, 85 KB
2019